:2em;'> Recently, major multinational pharmaceutical companies have successively announced their 2020 "transcripts. "
US FDA releases vaccine analysis report developed by Johnson & Johnson: Can prevent moderate to severe new crown infection
Time of Update: 2021-03-20
;">The report also stated that the vaccine's effectiveness and safety for people of different races are consistent. >According to CNN, the FDA's
Johnson & Johnson's COVID-19 vaccine Ad26.COV2.S has been approved by the FDA expert group
Time of Update: 2021-03-20
The filing documents of Johnson & Johnson are supported by data from the critical Phase III ENSEMBLE trial.
U.S. Drug Administration approves emergency use of Johnson & Johnson's new crown vaccine
Time of Update: 2021-03-17
The US Drug Administration said in a statement that this emergency use authorization allows the new crown vaccine to be distributed throughout the United States.
FDA approves Johnson and Johnson Darzalex Faspro treatment for light chain starch...
Time of Update: 2021-03-10
The U.S. Food and Drug Administration (FDA) has approved Darzalex Faspro of Johnson and Johnson's Xi'an Jansen to treat newly diagnosed adult patients with light-chain amyloid degeneration.
Johnson and Johnson Darzalex's off-the-skin preparations have been approved by the FDA for first-line treatment
Time of Update: 2021-03-10
in 2015, has become the backbone of clinical treatment MM therapy, widely used in first-line, second-line, multi-line treatment. darzalex subskin preparation (SC) was approved for listing in may and June 2020 in the United States (commodity name
Johnson and Johnson 2020Q3 results: Strong sales of $21.1 billion in immunology and oncology
Time of Update: 2021-03-06
Immunology and oncology performed well in the third quarter, Johnson and Johnson achieved double-digit growth in seven branded drugs (Erleada, Darzalex, Imbruvica, Stelara, Tremfya, Opsumit, Uptravi).
Vaccination 1 shot to prevent COVID-19! Johnson and Johnson single-dose new crown vaccine large
Time of Update: 2021-03-03
3 ENSEMBLE study aims to assess the effectiveness and safety of Jansen COVID-19 candidate vaccines in protecting moderate to severe COVID-19, with the common primary endpoint being 14 and 28 days after vaccination.
Johnson and Johnson Darzalex under-skin injections are approved by the European Union
Time of Update: 2021-03-03
by many countries around the world for first-, second-line, multi-line treatment of multiple myeloma, specifically approved adaptations vary from country to country, including: (1) November 2015, as a single-drug therapy, used in the past Adult
Bayer hired Marian de Barker of Johnson and Johnson to lead the pharmaceutical business
Time of Update: 2021-03-01
DeBaker recently served as Vice President of Operations and Divestitures at Johnson and Johnson Pharmaceuticals, responsible for leading Bayer's global external pharmaceutical growth strategy and activities in all key areas of pharmaceutical innovation and alliance management.
Sales soared and companies such as Johnson and Johnson used this method
Time of Update: 2021-03-01
May 14, according to the National Health and Health Commission, on the 13th of this month, 0-24 hours, three new confirmed cases, all local cases (2 cases in Liaoning, 1 case in Jilin); We can see that China
Johnson and Johnson contributed the most to second-quarter revenue of $20.8 billion in cancer drug sales
Time of Update: 2021-02-27
In the second quarter of 2018, Johnson and Johnson generated revenue of $20.8 billion, of which global cancer drug sales rose 42 percent to $2.46 billion.
New drugs for depression! Johnson and Johnson Spravato nasal spray approved in the European Union
Time of Update: 2021-02-27